MedTrace Logo

Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination

NCT02537756 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 737

Last updated 2020-05-18

No results posted yet for this study

Summary

HPV vaccine coverage among adolescents in the US is suboptimal. This is particularly true among traditionally underserved adolescents. Few parent-targeted interventions have focused on the parental decision-making process. Self-persuasion, generating one's own arguments for engaging in a behavior, may be an effective means to influence parents' motivation to vaccinate their children. In a three-phase study, investigators are using quantitative and qualitative research methods to develop and refine a tablet-based self-persuasion intervention for parents who are undecided about the HPV vaccine. This clinical trial submission focuses on the second phase of the study. The results of the second phase will inform the third phase of the trial (also registered in clinical trials).

Conditions

  • Human Papillomavirus Vaccines

Interventions

BEHAVIORAL

Project Voice

A tablet-based intervention that directs participants through different activities related to adolescent HPV vaccination based on their assigned condition

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Southern Methodist University

    collaborator OTHER

  • Parkland Health and Hospital System

    collaborator OTHER

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Jasmin A Tiro, PhD · UT Southwestern Medical Center

  • Austin S Baldwin, PhD · Southern Methodist University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-05
Primary Completion
2018-07-26
Completion
2019-10-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537756 on ClinicalTrials.gov